School of Medicine


Showing 1-10 of 17 Results

  • Eric J. Keller

    Eric J. Keller

    Affiliate, Dean's Office Operations - Dean Other
    Resident in Radiology

    BioEric J. Keller is an interventional/diagnostic radiology resident (2019-2024) with a background in bioethics, medical anthropology, 4D flow MRI, and legal guardianship. He founded the Applied Ethics in Interventional Radiology (IR) working group, a multi-institutional group of faculty and trainees developing practical approaches to challenging situations in IR. He also serves on the Board of Directors of the Interventional Initiative, a nonprofit devoted to patient and clinician awareness, access, and advocacy regarding minimally invasive image-guided procedures.

  • James Michael Kilgour

    James Michael Kilgour

    Affiliate, Dean's Office Operations - Dean Other
    Resident in Dermatology

    BioJames grew up in Oxford in the United Kingdom. He graduated from Cardiff University School of Medicine with honours in 2017, and has a BSc in Medical Education. Following graduation, he completed two years as a clinical academic in Dermatology at the University of Oxford, conducting research investigating patient-reported outcome measures and quality of life in patients with Graft-versus-Host-Disease following allogenic stem cell transplant. He subsequently completed a two year precision medicine fellowship at the Stanford University Department of Dermatology, focusing on cutaneous oncology and hidradenitis suppurativa. He has also extensively published in medical education, and co-founded a novel peer reviewed medical journal targeted at encouraging medical students to publish and peer review. He is currently completing his residency in Dermatology at Stanford.

  • Dan Seung Kim, MD, PhD, MPH

    Dan Seung Kim, MD, PhD, MPH

    Affiliate, Dean's Office Operations - Dean Other
    Fellow in Medicine
    Resident in Medicine

    Current Research and Scholarly InterestsMy research projects within the laboratory of Euan Ashley center around the broad topic of exercise, physiology, and cardiovascular disease:
    1. Digital health interventions - I previously have published on the topic of digital health interventions delivered via an iPhone app (Kim and Javed et al, European Heart Journal - Digital Health 2023). We found that personalizing interventions based on individual's baseline activity was more effective in increasing short-term physical activity than other "one-size fits all" approaches. In our next phase, we will extend this to under-represented populations in digital health and implement cutting-edge artificial intelligence models to improve our interventions.
    2. Molecular mechanisms of exercise physiologic adaptations - using time-series multi-omic data, we aim to map out the molecular responses to endurance exercise training in rats, using data from the Molecular Transducers of Physical Activity Consortium (MoTrPAC). See our recent review in Nature Reviews Genetics - Kim et al, 2021.
    3. Effect of physical activity on coronary artery disease symptoms and outcomes - in collaboration with Dr David Maron and the ISCHEMIA study, I am investigating the effects of physical activity and sedentary behavior on symptoms related to known coronary heart disease and separately, the outcome of all-cause mortality.
    4. Exercise [hysiology - in collaboration with Dr Francois Haddad and Dr Jonathan Myers, I am working on projects to better standardize reporting of maximal oxygen uptake. In brief, maximal oxygen uptake (VO2 max) is an extremely valuable prognostic, but estimation of this physiologic value is poor in certain populations. We are working to improve estimation of this variable and demonstrating its efficacy in predicting hard outcomes in patients with heart failure.
    5. Outcomes in inherited cardiomyopathies - under the mentorship of Dr Euan Ashley, I am building my clinical expertise in treating patients with inherited cardiomyopathies. The Stanford Center for Inherited Cardiovascular Disease (SCICD) is home to clinical care of patients with inherited cardiomyopathies, channelopathies, inherited lipid disorders, neuromuscular disorders (e.g., muscular dystrophy), and vascular disorders (e.g., Marfan's and other aorthopathies). Our clinic is nested within the Heart Failure program and manages those patients who are progressing toward advanced heart failure therapies, such as transplant or left ventricular assist devices. Within this clinic, I am leading projects to describe our experience with mavacamten, a first of its class treatment of hypertrophic cardiomyopathy with obstruction.

  • Hanna Maria Knihtila

    Hanna Maria Knihtila

    Affiliate, Dean's Office Operations - Dean Other
    Resident in Pediatrics

    BioHanna Knihtila is a Pediatrics Resident at Stanford. She gained her MD in 2017 and PhD in 2018 from the University of Helsinki, Finland. She then completed her 2-year postdoctoral research fellowship at the Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School before joining Stanford for her residency training.